Patent · US Active

Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases

US8536185B2 · kind B2 · utility

1Cited by

5References

57Claims

0Family size

Assignee

CAYMAN CHEMICAL COMPANY, INC. · US

Inventors

Gregory William Endres · Saline, US
Pil Heui Lee · Chelsea, US
Kirk L. Olson · Canton, US
James Bernard Kramer · Sylvania, US
Fred Lawrence Ciske · Dexter, US
Stephen Douglas Barrett · Hartland, US

Key dates

Filing date	Sep 22, 2009
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Nov 26, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.